By Jeff Overley ( September 28, 2017, 7:37 PM EDT) -- Hospira Inc. on Wednesday attacked a $70 million jury verdict for patent infringement related to its proposed biosimilar of Amgen Inc.'s anemia drug Epogen, telling a Delaware federal judge that it is shielded by a safe harbor....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.